Clinical Trial Detail

NCT ID NCT01324180
Title Vincristine, Dexamethasone, Doxorubicin, and PEG-asparaginase (VPLD) and Metformin for Relapsed Childhood Acute Lymphoblastic Leukemia (ALL)
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors H. Lee Moffitt Cancer Center and Research Institute
Indications

non-Hodgkin lymphoma

acute lymphoblastic leukemia

Therapies

Metformin

Dexamethasone + Doxorubicin + Pegaspargase + Vincristine Sulfate

Age Groups: child adult

No variant requirements are available.